Here's the live share price of Entero Healthcare Solutions along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Entero Healthcare Solutions has declined 0.81% CAGR. Over the past year, the corresponding return has been -19.93%.
Entero Healthcare Solutions’s current P/E of 46.82x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Entero Healthcare Solutions | 1.65 | 0.62 | -14.17 | -14.44 | -19.93 | -1.35 | -0.81 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 9.18 | 53.86 | 94.04 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -16.91 | -8.00 | -3.51 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
Over the last one year, Entero Healthcare Solutions has declined 19.93% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, Entero Healthcare Solutions has underperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,107.49 | 1,105.98 |
| 10 | 1,104.53 | 1,106.29 |
| 20 | 1,105.38 | 1,110.62 |
| 50 | 1,148.52 | 1,138.67 |
| 100 | 1,178.39 | 1,176.55 |
| 200 | 1,241.6 | 1,208.38 |
In the latest quarter, Entero Healthcare Solutions remained same as its previous close in promoter holding, while DII stake decreased to 9.64%, FII holding fell to 14.68%, and public shareholding moved up to 23.26% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 15,77,379 | 0.92 | 175.74 | |
| 2,25,000 | 0.9 | 25.07 | |
| 30,000 | 0.42 | 3.34 | |
| 21,400 | 0.99 | 2.38 |
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Oct 29, 2025, 4:54 PM IST | Entero Healthcare So - Board Meeting Intimation for Approval Of The Financial Results For The Quarter Ended September 30, 202 |
| Oct 08, 2025, 10:55 PM IST | Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Oct 08, 2025, 10:45 PM IST | Entero Healthcare So - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 03, 2025, 11:06 PM IST | Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Sep 29, 2025, 7:03 PM IST | Entero Healthcare So - Announcement under Regulation 30 (LODR)-Diversification / Disinvestment |
Entero Healthcare Solutions Ltd. is a Public Limited Listed company incorporated on 10/01/2018 and has its registered office in the State of Haryana, India. Company's Corporate Identification Number(CIN) is L74999HR2018PLC072204 and registration number is 072204. Currently Company is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company's Total Operating Revenue is Rs. 408.67 Cr. and Equity Capital is Rs. 43.51 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Entero Healthcare Solutions is ₹1,103.50 as on Oct 31, 2025.
The Entero Healthcare Solutions is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Entero Healthcare Solutions is ₹4,801.21 Cr as on Oct 31, 2025.
Today’s highest and lowest price of Entero Healthcare Solutions are ₹1,108.00 and ₹1,095.00.
The 52-week high/low is the highest and lowest price at which Entero Healthcare Solutions stock has traded in the past 52-week or nearly a year. The 52-week high of Entero Healthcare Solutions is ₹1,583.00 and 52-week low of Entero Healthcare Solutions is ₹1,045.00 as on Oct 31, 2025.
The Entero Healthcare Solutions has shown returns of -0.26% over the past day, 0.62% for the past month, -14.17% over 3 months, -19.93% over 1 year, -1.35% across 3 years, and -0.81% over 5 years.
P/E ratio of and PB ratio of Entero Healthcare Solutions are 46.82 and 2.85 on Oct 31, 2025. While the company gives a dividend yield of 0.00 per annum.